Proteomic profiling reveals potential mechanisms regulating acquisition of luteolytic capacity in the bovine corpus luteum
Biology of Reproduction · 15.07.2026 · 115 (1) · 178-193
DOI: 10.1093/biolre/ioag059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Reproduction, online erschienen am 11.03.2026. Verfasst von Jillian M Hughes-Brown und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, Pennsylvania State University, State College, PA, USA. Hauptthemen laut MEDLINE: Corpus Luteum, Luteolysis. Die Arbeit nennt 98 Literaturangaben. Gefördert von: USDA Agriculture and Food Research Initiative Predoctoral Fellowship, USDA National Institute of Food and Agriculture and Multistate/Regional Research Appropriations, USDA National Institute of Food and Agriculture and Hatch Appropriations.
Abstract (Originalsprache)
The corpus luteum (CL) produces progesterone to support pregnancy but undergoes luteolysis in response to prostaglandin F2A (PGF2A) when pregnancy is absent. Developing CL resist PGF2A-induced regression. This acquisition of luteolytic capacity (ALC) occurs around day 5 of the estrous cycle in cattle. To understand the mechanisms underlying ALC, we evaluated transcriptomic and proteomic changes in the CL on days 4 and 6 of the estrous cycle. One thousand one hundred ninety transcripts were greater on day 4 and 119 were greater on day 6 (Padj <0.05, log2FC > |1|). In the proteomics dataset, 2 proteins were greater on day 4, with 12 greater on day 6 (Padj <0.05, log2FC > |1|). Data were integrated with datasets of luteal changes during luteolysis and during early pregnancy, and gene ontology analysis was used to identify candidate pathways regulating luteal PGF2A responsiveness, including apoptosis, cellular stress response, and cytokine signaling. Apoptosis regulators increased on day 6 and increased in response to PGF2A in vivo, indicating a likely role in luteolytic cell death. Changes to regulators of antigen presentation and T-cell programming suggested increased T-cell activation on day 6. A luteal cell culture experiment revealed that apoptosis pathways were regulated by interferon gamma and immune pathways were regulated by luteinizing hormone in vitro. In summary, integration across datasets from multiple luteal states allowed identification of proposed mediators governing luteal survival and PGF2A response. Apoptosis and immune-related pathways, changes indicating increased activated T cells, may poise the CL to regress in response to PGF2A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Science, Pennsylvania State University, State College, PA, USA.
ORCID-Profile: Camilla H K Hughes
Förderung
- USDA Agriculture and Food Research Initiative Predoctoral Fellowship
- USDA National Institute of Food and Agriculture and Multistate/Regional Research Appropriations
- USDA National Institute of Food and Agriculture and Hatch Appropriations
- Penn State start-up funding to CHKH
- The Huck Institutes of the Life Sciences start-up core facilities funds to CHKH
Zitieren
APA
Hughes-Brown, J. M., Medich, E. H., Pate, J. L., & Hughes, C. H. K. (2026). Proteomic profiling reveals potential mechanisms regulating acquisition of luteolytic capacity in the bovine corpus luteum. Biology of Reproduction, 115(1), 178-193. https://doi.org/10.1093/biolre/ioag059
Vancouver
Hughes-Brown JM, Medich EH, Pate JL, Hughes CHK. Proteomic profiling reveals potential mechanisms regulating acquisition of luteolytic capacity in the bovine corpus luteum. Biology of Reproduction. 2026;115(1):178-193. doi:10.1093/biolre/ioag059
BibTeX
@article{HughesBrown2026,
author = {Hughes-Brown, Jillian M and Medich, Elizabeth H and Pate, Joy L and Hughes, Camilla H K},
title = {Proteomic profiling reveals potential mechanisms regulating acquisition of luteolytic capacity in the bovine corpus luteum},
journal = {Biology of Reproduction},
year = {2026},
volume = {115},
number = {1},
pages = {178--193},
doi = {10.1093/biolre/ioag059}
}
EUVIMED